Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to one1 As type 2 diabetes incidence rates among youth…
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
The European Commission’s decision will make the product the first disease-modifying treatment to be available for the condition in Europe. The European Commission has approved Teizeild (teplizumab) as the first…
MedWatchUS FDA grants priority review for Sanofi’s type 1 diabetes drugFrance is seeking fast-track approval of diabetes drug Tzield in children aged over one..2 hours ago
Nov 14 (Reuters) – The European Medicines Agency’s committee has recommended approval of French drugmaker Sanofi’s (SASY.PA)opens new tab first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of…
Editor's Note: This article has been edited to clarify the title of Dr. Galimella as MBBS, MPH. In an interview with Pharmacy Times®, Pranav Garimella, MBBS, MPH, chief medical officer…
June 15, 2024 by Holly Honderich, BBC News Getty Images Continuous glucose monitors have become a powerful tool for people with diabetes Blood glucose monitoring devices may soon be on…
App for Gaithersburg teens with diabetes awaits FDA approval The app, called T1D1, became popular. It has been downloaded over 45,000 times. 13-year-old Drew Mendelow’s doctor has recommended it to…